Guardant Health Inc at Goldman Sachs Global Healthcare Conference Transcript
Good morning, everyone. Thanks for joining us. I'm Matt Sykes, the Life Sciences Tools and Diagnostics Analyst at Goldman Sachs. And this morning, we have the pleasure of welcoming senior management from Guardant Health, Helmy Eltoukhy and AmirAli Talasaz, the Co-Chief Executive Officers; and Michael Bell, the Chief Financial Officer.
Gentlemen, welcome. Thank you for joining us today.
Questions & Answers
Maybe we could start out by just by having you set the stage for some key highlights in the first half of the year and maybe what investors should be focused on for the balance of '22?
Yes. Thank you for having us here. It's always great to be in this wonderful venue. This has been really, I would say, instrumental and pivotal year for us in terms of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
